Apyx Medical Corp financial data

Symbol
APYX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5115 Ulmerton Road, Clearwater, Florida
State of incorporation
Delaware
Fiscal year end
December 31
Former names
BOVIE MEDICAL CORP (to 1/2/2019), BOVIE MEDICAL Corp (to 1/2/2019), AN CON GENETICS INC (to 1/13/1999)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 447 % +23%
Quick Ratio 80.1 % -4.61%
Debt-to-equity 132 % +250%
Return On Equity -77.5 % -51.8%
Return On Assets -33.6 % +9.59%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.6 M shares +0.13%
Common Stock, Shares, Outstanding 34.6 M shares +0.13%
Entity Public Float 168 M USD -16.9%
Common Stock, Value, Issued 35 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 34.6 M shares +0.13%
Weighted Average Number of Shares Outstanding, Diluted 34.6 M shares +0.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 50.5 M USD +14.2%
Research and Development Expense 4.97 M USD +6.72%
Operating Income (Loss) -18.3 M USD +21.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23 M USD -0.91%
Income Tax Expense (Benefit) -112 K USD +94.3%
Net Income (Loss) Attributable to Parent -22.8 M USD -10.1%
Earnings Per Share, Basic -0.66 USD/shares -10%
Earnings Per Share, Diluted -0.66 USD/shares -10%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.3 M USD +129%
Accounts Receivable, after Allowance for Credit Loss, Current 12.5 M USD +25.3%
Inventory, Net 9.8 M USD -10.5%
Assets, Current 61.9 M USD +17.5%
Property, Plant and Equipment, Net 1.78 M USD -15.6%
Operating Lease, Right-of-Use Asset 5.05 M USD +682%
Other Assets, Noncurrent 1.89 M USD +52.8%
Assets 70.7 M USD +24.5%
Accounts Payable, Current 2.1 M USD +10.4%
Employee-related Liabilities, Current 1.28 M USD
Accrued Liabilities, Current 8.93 M USD -13.2%
Contract with Customer, Liability, Current 515 K USD -51.1%
Liabilities, Current 10.6 M USD -43%
Contract with Customer, Liability, Noncurrent 1.25 M USD -6.78%
Operating Lease, Liability, Noncurrent 4.8 M USD +970%
Other Liabilities, Noncurrent 194 K USD +4.87%
Liabilities 50.3 M USD +144%
Retained Earnings (Accumulated Deficit) -62 M USD -58.2%
Stockholders' Equity Attributable to Parent 20.3 M USD -43.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 20.5 M USD -43.5%
Liabilities and Equity 70.7 M USD +24.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.34 M USD -237%
Net Cash Provided by (Used in) Financing Activities -5 K USD -100%
Net Cash Provided by (Used in) Investing Activities -35 K USD +68.2%
Common Stock, Shares Authorized 75 M shares 0%
Common Stock, Shares, Issued 34.6 M shares +0.13%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.37 M USD -205%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37.3 M USD +129%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.18 M USD +117400%
Deferred Tax Assets, Valuation Allowance 16.4 M USD +36.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 18 M USD +44%
Operating Lease, Liability 5.24 M USD +664%
Depreciation 700 K USD 0%
Payments to Acquire Property, Plant, and Equipment 35 K USD -68.2%
Lessee, Operating Lease, Liability, to be Paid 7.79 M USD +987%
Property, Plant and Equipment, Gross 5.04 M USD -55.4%
Operating Lease, Liability, Current 356 K USD +93.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 805 K USD +560%
Lessee, Operating Lease, Liability, to be Paid, Year One 778 K USD +240%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +236%
Deferred Income Tax Expense (Benefit) -4.38 M USD +14.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.55 M USD +8119%
Lessee, Operating Lease, Liability, to be Paid, Year Three 832 K USD +582%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -3.39 M USD +17.3%
Current Income Tax Expense (Benefit) -2.43 M USD -763%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 860 K USD +605%
Operating Lease, Payments 643 K USD +194%
Additional Paid in Capital 82.2 M USD +9.31%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 29 K USD 0%
Current Federal Tax Expense (Benefit) -2.65 M USD -1336%
Depreciation, Depletion and Amortization 157 K USD -22.7%
Deferred Tax Assets, Net of Valuation Allowance 1.59 M USD +248%
Share-based Payment Arrangement, Expense 4.88 M USD -24%
Deferred State and Local Income Tax Expense (Benefit) -989 K USD +1.49%
Interest Expense 3.64 M USD +1410%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%